The long-term objective of this proposal is to advance our knowledge of the neurobiology of opiate abuse by understanding how opioids affect mechanisms of neuroendocrine regulation. The current proposal will focus on the endogenous opioid precursor proopiomelanocortin (POMC) in the hypothalamus and its interactions with corticotropin releasing hormone (CRH) which plays a critical role in coordinating the neuroendocrine response to stress. Two POMC derived peptides, beta-endorphin and a-MSH, have important neuroendocrine effects and have been implicated in the stress response and in the regulation of the hypothalamic-pituitary-adrenal (HPA) axis. This proposal examines the HPA and cytokine responses to inflammatory stress and on the disruptive effects of opioid drugs on these processes. It focuses on the regulation of POMC and CRH in the hypothalamus of the rat when the HPA axis is activated by inflammatory ;cytokines (IL 1, IL-6 and TNFa). The effect of these cytokines, either administered exogenously or released endogenously in response to endotoxin, on POMC gene expression and peptide levels in the hypothalamus will be studied and the role of POMC peptides in limiting or terminating the effects of these cytokines on the HPA axis will be determined. The effect of treatment with opioid agonists and antagonists on cytokine-CRH-POMC interactions in brain will also be studied. Specifically the ability of chronic morphine treatment and withdrawal to affect basal and IL-l stimulated expression of the CRH gene and its recently cloned receptor will be studied in the hypothalamus and correlated with the functional effects of these treatments on ACTH, corticosterone and IL-6 release in chronically catheterized animals. Neuropeptide gene expression and peptide levels will be studied by sensitive solution hybridization assays, complemented by in situ hybridization, and well characterized radioimmunoassays. These studies should have direct relevance to the clinical problem of drug abuse. Infection, with associated cytokine release, has always been a major complication of intravenous drug abuse even before the era of HIV infection. lt is thus important to know how opioid drug use and withdrawal affect cytokine mediated HPA responses especially since these interactions may also play a critical role in regulating the immune response. The studies outlined in this proposal should provide important new information about the neuroendocrine response to stress which should have broader implications for the regulation of immune function through interactions with the neuroendocrine system.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA007732-06
Application #
2897880
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Thadani, Pushpa
Project Start
1992-04-01
Project End
2001-04-30
Budget Start
1999-05-01
Budget End
2000-04-30
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Wardlaw, S L (2001) Clinical review 127: Obesity as a neuroendocrine disease: lessons to be learned from proopiomelanocortin and melanocortin receptor mutations in mice and men. J Clin Endocrinol Metab 86:1442-6
Korner, J; Savontaus, E; Chua Jr, S C et al. (2001) Leptin regulation of Agrp and Npy mRNA in the rat hypothalamus. J Neuroendocrinol 13:959-66
Papadopoulos, A D; Wardlaw, S L (2000) Testosterone suppresses the response of the hypothalamic-pituitary-adrenal axis to interleukin-6. Neuroimmunomodulation 8:39-44
Korner, J; Wardlaw, S L; Liu, S M et al. (2000) Effects of leptin receptor mutation on Agrp gene expression in fed and fasted lean and obese (LA/N-faf) rats. Endocrinology 141:2465-71
Korner, J; Chua Jr, S C; Williams, J A et al. (1999) Regulation of hypothalamic proopiomelanocortin by leptin in lean and obese rats. Neuroendocrinology 70:377-83
Papadopoulos, A D; Wardlaw, S L (1999) Endogenous alpha-MSH modulates the hypothalamic-pituitary-adrenal response to the cytokine interleukin-1beta. J Neuroendocrinol 11:315-9
Wardlaw, S L; McCarthy, K C; Conwell, I M (1998) Glucocorticoid regulation of hypothalamic proopiomelanocortin. Neuroendocrinology 67:51-7
Sullivan, G M; Canfield, S M; Lederman, S et al. (1997) Intracerebroventricular injection of interleukin-1 suppresses peripheral lymphocyte function in the primate. Neuroimmunomodulation 4:12-8
Wardlaw, S L; Kim, J; Sobieszczyk, S (1996) Effect of morphine on proopiomelanocortin gene expression and peptide levels in the hypothalamus. Brain Res Mol Brain Res 41:140-7
Xia, L; Matera, C; Ferin, M et al. (1996) Interleukin-1 stimulates the central release of corticotropin-releasing hormone in the primate. Neuroendocrinology 63:79-84

Showing the most recent 10 out of 12 publications